Stock Track | McKesson (MCK) Stock Plummets 5.10% on Disappointing Q3 Results and Margin Contraction

Stock Track

Feb 06, 2025

McKesson Corporation (MCK) shares plummeted 5.10% in pre-market trading on Thursday, February 6, following the company's disappointing third-quarter fiscal 2025 results and contraction in gross margin.

The healthcare services and information technology company missed analysts' expectations for both earnings and revenue in the third quarter. McKesson reported adjusted earnings per share (EPS) of $8.03, slightly below the consensus estimate of $8.04. The company's revenue of $95.29 billion also fell short of expectations, missing the Zacks Consensus Estimate by 0.2%.

While McKesson's revenue grew 17.8% year-over-year, driven by continued momentum in the Pharmaceutical segment and increased prescription volumes, the company's gross margin declined nearly 40 basis points to 3.5% of net revenues. Higher costs of sales and operating expenses contributed to the margin contraction, raising concerns among investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1112292977"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112292977\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1112292977?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-06 23:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112292977","market":"us","top_or_hot":-1,"title":"Stock Track | McKesson (MCK) Stock Plummets 5.10% on Disappointing Q3 Results and Margin Contraction","media":"Stock Track","content":"<p>McKesson Corporation (MCK) shares plummeted 5.10% in pre-market trading on Thursday, February 6, following the company's disappointing third-quarter fiscal 2025 results and contraction in gross margin.</p>\n\n<p>The healthcare services and information technology company missed analysts' expectations for both earnings and revenue in the third quarter. McKesson reported adjusted earnings per share (EPS) of $8.03, slightly below the consensus estimate of $8.04. The company's revenue of $95.29 billion also fell short of expectations, missing the Zacks Consensus Estimate by 0.2%.</p>\n\n<p>While McKesson's revenue grew 17.8% year-over-year, driven by continued momentum in the Pharmaceutical segment and increased prescription volumes, the company's gross margin declined nearly 40 basis points to 3.5% of net revenues. Higher costs of sales and operating expenses contributed to the margin contraction, raising concerns among investors.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | McKesson (MCK) Stock Plummets 5.10% on Disappointing Q3 Results and Margin Contraction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | McKesson (MCK) Stock Plummets 5.10% on Disappointing Q3 Results and Margin Contraction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-06 23:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>McKesson Corporation (MCK) shares plummeted 5.10% in pre-market trading on Thursday, February 6, following the company's disappointing third-quarter fiscal 2025 results and contraction in gross margin.</p>\n\n<p>The healthcare services and information technology company missed analysts' expectations for both earnings and revenue in the third quarter. McKesson reported adjusted earnings per share (EPS) of $8.03, slightly below the consensus estimate of $8.04. The company's revenue of $95.29 billion also fell short of expectations, missing the Zacks Consensus Estimate by 0.2%.</p>\n\n<p>While McKesson's revenue grew 17.8% year-over-year, driven by continued momentum in the Pharmaceutical segment and increased prescription volumes, the company's gross margin declined nearly 40 basis points to 3.5% of net revenues. Higher costs of sales and operating expenses contributed to the margin contraction, raising concerns among investors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MCK","symbol_name":"麦克森药物批发","start_time":0,"source_url":"","article_id":"1112292977","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112292977","pubTimestamp":1738854383,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"McKesson Corporation  shares plummeted 5.10% in pre-market trading on Thursday, February 6, following the company's disappointing third-quarter fiscal 2025 results and contraction in gross margin.The healthcare services and information technology company missed analysts' expectations for both earnings and revenue in the third quarter. McKesson reported adjusted earnings per share  of $8.03, slightly below the consensus estimate of $8.04. The company's revenue of $95.29 billion also fell short of","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MCK":"麦克森药物批发"},"translate_title":"股票轨迹McKesson(MCK)股价因第三季度业绩令人失望和利润率收缩而暴跌5.10%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MCK":1},"content_text":"McKesson Corporation (MCK) shares plummeted 5.10% in pre-market trading on Thursday, February 6, following the company's disappointing third-quarter fiscal 2025 results and contraction in gross margin.\nThe healthcare services and information technology company missed analysts' expectations for both earnings and revenue in the third quarter. McKesson reported adjusted earnings per share (EPS) of $8.03, slightly below the consensus estimate of $8.04. The company's revenue of $95.29 billion also fell short of expectations, missing the Zacks Consensus Estimate by 0.2%.\nWhile McKesson's revenue grew 17.8% year-over-year, driven by continued momentum in the Pharmaceutical segment and increased prescription volumes, the company's gross margin declined nearly 40 basis points to 3.5% of net revenues. Higher costs of sales and operating expenses contributed to the margin contraction, raising concerns among investors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}